Literature DB >> 28438925

Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.

Gopinath Viswanathan1, Sangya Yadav1, Tirumalai R Raghunand2.   

Abstract

In a Mycobacterium smegmatis mutant library screen, transposon mutants with insertions in fhaA, dprE2, rpsT, and parA displayed hypersusceptibility to antibiotics, including the β-lactams meropenem, ampicillin, amoxicillin, and cefotaxime. Sub-MIC levels of octoclothepin, a psychotic drug inhibiting ParA, phenocopied the parA insertion and enhanced the bactericidal activity of meropenem against Mycobacterium tuberculosis in combination with clavulanate. Our study identifies novel factors associated with antibiotic resistance, with implications in repurposing β-lactams for tuberculosis treatment.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium smegmatis; Mycobacterium tuberculosis; ParA; meropenem; octoclothepin; β-lactams

Mesh:

Substances:

Year:  2017        PMID: 28438925      PMCID: PMC5487644          DOI: 10.1128/AAC.00425-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.

Authors:  Saverio De Lorenzo; Jan Wilem Alffenaar; Giovanni Sotgiu; Rosella Centis; Lia D'Ambrosio; Simon Tiberi; Mathieu S Bolhuis; Richard van Altena; Piero Viggiani; Andrea Piana; Antonio Spanevello; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2012-09-20       Impact factor: 16.671

Review 2.  Advances in the development of new tuberculosis drugs and treatment regimens.

Authors:  Alimuddin Zumla; Payam Nahid; Stewart T Cole
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

3.  Qualitative and quantitative drug-susceptibility tests in mycobacteriology.

Authors:  L Heifets
Journal:  Am Rev Respir Dis       Date:  1988-05

4.  Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt₁ by carbapenems and cephalosporins.

Authors:  Vincent Dubée; Sébastien Triboulet; Jean-Luc Mainardi; Mélanie Ethève-Quelquejeu; Laurent Gutmann; Arul Marie; Lionel Dubost; Jean-Emmanuel Hugonnet; Michel Arthur
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

5.  Identification of novel loci associated with mycobacterial isoniazid resistance.

Authors:  Gopinath Viswanathan; Sangya Yadav; Tirumalai R Raghunand
Journal:  Tuberculosis (Edinb)       Date:  2015-11-05       Impact factor: 3.131

6.  Insights into the function of FhaA, a cell division-associated protein in mycobacteria.

Authors:  Gopinath Viswanathan; Sangya Yadav; Shrilaxmi V Joshi; Tirumalai R Raghunand
Journal:  FEMS Microbiol Lett       Date:  2017-01-01       Impact factor: 2.742

7.  Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.

Authors:  Nicolas Dauby; Inge Muylle; Françoise Mouchet; Roger Sergysels; Marie-Christine Payen
Journal:  Pediatr Infect Dis J       Date:  2011-09       Impact factor: 2.129

8.  FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis.

Authors:  Liem Nguyen; Satheesh Chinnapapagari; Charles J Thompson
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

9.  ParA of Mycobacterium smegmatis co-ordinates chromosome segregation with the cell cycle and interacts with the polar growth determinant DivIVA.

Authors:  Katarzyna Ginda; Martyna Bezulska; Małgorzata Ziółkiewicz; Jarosław Dziadek; Jolanta Zakrzewska-Czerwińska; Dagmara Jakimowicz
Journal:  Mol Microbiol       Date:  2013-01-28       Impact factor: 3.501

10.  In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.

Authors:  Suresh Solapure; Neela Dinesh; Radha Shandil; Vasanthi Ramachandran; Sreevalli Sharma; Deepa Bhattacharjee; Samit Ganguly; Jitendar Reddy; Vijaykamal Ahuja; Vijender Panduga; Manish Parab; K G Vishwas; Naveen Kumar; Meenakshi Balganesh; V Balasubramanian
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

View more
  2 in total

1.  Disrupting coupling within mycobacterial F-ATP synthases subunit ε causes dysregulated energy production and cell wall biosynthesis.

Authors:  Wuan-Geok Saw; Mu-Lu Wu; Priya Ragunathan; Goran Biuković; Aik-Meng Lau; Joon Shin; Amaravadhi Harikishore; Chen-Yi Cheung; Kiel Hards; Jickky Palmae Sarathy; Roderick W Bates; Gregory M Cook; Thomas Dick; Gerhard Grüber
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

Review 2.  Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era.

Authors:  Alina Minias; Lidia Żukowska; Ewelina Lechowicz; Filip Gąsior; Agnieszka Knast; Sabina Podlewska; Daria Zygała; Jarosław Dziadek
Journal:  Front Microbiol       Date:  2021-02-02       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.